These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 15450264)

  • 1. [Genetic analysis of the fetus using maternal blood].
    Costa JM; Gautier E; Benachi A
    Gynecol Obstet Fertil; 2004; 32(7-8):646-50. PubMed ID: 15450264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RHD genotyping from maternal plasma: guidelines and technical challenges.
    Avent ND
    Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New non-invasive technique for prenatal diagnosis: analysis of maternal blood].
    Costa JM
    J Gynecol Obstet Biol Reprod (Paris); 2003 Feb; 32(1 Suppl):1S48-9. PubMed ID: 12592163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive fetal RhD genotyping from maternal blood.
    Kolialexi A; Tounta G; Mavrou A
    Expert Rev Mol Diagn; 2010 Apr; 10(3):285-96. PubMed ID: 20370586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fetal DNA in maternal blood].
    Rijnders RJ; Christiaens GC; de Haas M; van der Schoot CE
    Ned Tijdschr Geneeskd; 2004 Jan; 148(4):170-4. PubMed ID: 14974307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non invasive prenatal genetic diagnosis of fetal RhD and sex through the analysis of free fetal DNA in maternal plasma].
    Sesarini C; Giménez ML; Redal MA; Izbizky G; Aiello H; Argibay P; Otaño L
    Arch Argent Pediatr; 2009 Oct; 107(5):405-9. PubMed ID: 19809760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of maternal plasma for prenatal RhD blood group genotyping.
    Finning K; Martin P; Daniels G
    Methods Mol Biol; 2009; 496():143-57. PubMed ID: 18839110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in non-invasive prenatal DNA diagnosis through analysis of maternal blood.
    Sekizawa A; Purwosunu Y; Matsuoka R; Koide K; Okazaki S; Farina A; Saito H; Okai T
    J Obstet Gynaecol Res; 2007 Dec; 33(6):747-64. PubMed ID: 18001438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymerase-chain-reaction-based detection of fetal rhesus D and Y-chromosome-specific DNA in the whole blood of pregnant women during different trimesters of pregnancy.
    Al-Yatama MK; Mustafa AS; Al-Kandari FM; Khaja N; Zohra K; Monem RA; Abraham S
    Med Princ Pract; 2007; 16(5):327-32. PubMed ID: 17709918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma.
    Lo YM; Hjelm NM; Fidler C; Sargent IL; Murphy MF; Chamberlain PF; Poon PM; Redman CW; Wainscoat JS
    N Engl J Med; 1998 Dec; 339(24):1734-8. PubMed ID: 9845707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility study of using fetal DNA in maternal plasma for non-invasive prenatal diagnosis.
    Liu FM; Wang XY; Feng X; Wang W; Ye YX; Chen H
    Acta Obstet Gynecol Scand; 2007; 86(5):535-41. PubMed ID: 17464580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies.
    Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Vlk R
    J Histochem Cytochem; 2005 Mar; 53(3):301-5. PubMed ID: 15750007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive fetal RHD genotyping from maternal plasma. Use of a new developed Free DNA Fetal Kit RhD.
    Rouillac-Le Sciellour C; Sérazin V; Brossard Y; Oudin O; Le Van Kim C; Colin Y; Guidicelli Y; Menu M; Cartron JP
    Transfus Clin Biol; 2007 Dec; 14(6):572-7. PubMed ID: 18375165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal diagnosis of the fetal RhD blood type using a single fetal nucleated erythrocyte from maternal blood.
    Sekizawa A; Watanabe A; Kimura T; Saito H; Yanaihara T; Sato T
    Obstet Gynecol; 1996 Apr; 87(4):501-5. PubMed ID: 8602298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.
    Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Köhler M; Legler TJ
    Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antenatal determination of fetal RhD-blood type based on fetal DNA in plasma from the RhD-negative mother--secondary publication].
    Clausen FB; Krog GR; Rieneck K; Nielsen LK; Lundquist R; Finning K; Dickmeiss E; Hedegaard M; Dziegiel MH
    Ugeskr Laeger; 2006 Jun; 168(26-32):2568-70. PubMed ID: 16824414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal fetal blood group genotyping.
    Lo YM
    Transfus Clin Biol; 2006; 13(1-2):50-2. PubMed ID: 16563836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fetal RHD genotyping by PCR using plasma from D negative pregnant women].
    Achargui S; Tijane M; Benchemsi N
    Transfus Clin Biol; 2011 Feb; 18(1):13-9. PubMed ID: 21190884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma.
    Grootkerk-Tax MG; Soussan AA; de Haas M; Maaskant-van Wijk PA; van der Schoot CE
    Transfusion; 2006 Dec; 46(12):2142-8. PubMed ID: 17176327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prenatal genotyping of the RhD locus by polymerase chain reaction in fetus at risk of hemolytic disease].
    Misković B; Stipoljev F; Hadzisejdić I; Grahovac B
    Lijec Vjesn; 2008; 130(1-2):4-6. PubMed ID: 18589635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.